SPHK1 and exocrine pancreatic carcinoma: Several studies have demonstrated that SK inhibition prevents the metastasis of several cancers, including pancreatic carcinoma [33,34,35], where the overexpression of SK1 is associated with chemotherapeutic drug resistance, and inhibiting SK1 could be a potential strategy to treat PDAC patients who have developed drug resistance [36].